Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Protara Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:TARA | Benzinga

Q: What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Protara Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TARA.

Open	$4.23
Close	-
Volume / Avg.	222.08K / 296.33K
Day Range	$4.13 - $4.28
52 Wk Range	1.60 - 10.48
Market Cap	$154.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.58%
Days to Cover	9.22

Recent News

This H.B. Fuller Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Avi Kapoor

This UroGen Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.23
Close	-
Volume / Avg.	222.08K / 296.33K
Day Range	$4.13 - $4.28
52 Wk Range	1.60 - 10.48
Market Cap	$154.42M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	6.58%
Days to Cover	9.22

About Protara Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for peop...

Got Questions? Ask

How has TARA's EPS changed?

What are analysts' targets for TARA?

What is TARA's drawdown from recent high?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Protara Therapeutics (TARA) stock?

You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.

View our list of the best stock brokerages

Who are Protara Therapeutics (TARA) competitors?

Other companies in Protara Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Quoin Pharmaceuticals (NASDAQ:QNRX).

What is the forecast, or price target, for Protara Therapeutics (TARA) stock?

Protara Therapeutics has a consensus price target of $20.67.

What is the current price for Protara Therapeutics (TARA)?

The stock price for Protara Therapeutics (NASDAQ: TARA) is $4.16 last updated April 24, 2025 at 3:34 PM EDT.

Does Protara Therapeutics (TARA) pay a dividend?

There are no upcoming dividends for Protara Therapeutics.

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

Protara Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Protara Therapeutics (TARA) going to split?

There is no upcoming split for Protara Therapeutics.

What sector and industry does Protara Therapeutics (TARA) operate in?

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Protara Therapeutics Stock Price, Quotes and Forecasts

Protara Therapeutics (TARA) Forecast